Clozapine-induced fatal fulminant hepatic failure: A case report

Canadian Journal of Gastroenterology

Volumn 23, Issue 5, 2009, Pages 376-378

  Chang, Albert ^a   Krygier, Darin S ^a   Chatur, Nazira ^a   Yoshida, Eric M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Clozapine; Fulminant hepatic failure; Schizophrenia

Indexed keywords

ALBUMIN; CLOZAPINE; FRESH FROZEN PLASMA; LACTULOSE; NEUROLEPTIC AGENT;

ABDOMINAL DISTENSION; ABDOMINAL RADIOGRAPHY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANOREXIA; ARTICLE; ARTIFICIAL VENTILATION; ASCITES; BLOOD CLOTTING DISORDER; CASE REPORT; CLINICAL FEATURE; DELUSION; DISEASE SEVERITY; DOPPLER FLOWMETRY; DOSE RESPONSE; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL DISEASE; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; HYPOTHERMIA; JAUNDICE; KIDNEY FUNCTION; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER FAILURE; LIVER NECROSIS; MULTIPLE ORGAN FAILURE; NAUSEA; PARACENTESIS; PARANOID SCHIZOPHRENIA; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SLEEP AROUSAL DISORDER; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UPPER ABDOMINAL PAIN; VOMITING; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; FATALITY; MIDDLE AGED;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; LIVER FAILURE, ACUTE; MIDDLE AGED; SCHIZOPHRENIA, PARANOID;

EID: 67649981417     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/503916     Document Type: Article

References (11)

1. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
2. Macfarlane B, Davies S, Mannan K, et al. Fatal acute fulminant liver failure due to clozapine: A case report and review of clozapine-induced hepatotoxicity. Gastroenterology 1997;112:1707-9.
3. Pelizza L, De Luca P, La Pesa M, et al. Clozapine-induced intestinal occlusion: A serious side effect. Acta Biomed 2007;78:144-8.
4. Luo D, McColl P, Walmsley R. Acute onset of ascites with clozapine-induced hepatitis. Internal Med J 2007;37:204-5.
5. Worrall R, Wilson A, Cullen M. Dystonia and drug-induced hepatitis in a patient treated with clozapine. Am J Psychiatry 1995;152:647-8.
6. Wirshing WC, Ames D, Bisheff S, et al. Hepatic encephalopathy associated with combined clozapine and divalproex sodium treatment. J Clin Psychopharmacol 1997;17:120-1.
7. Thatcher GW, Cates M, Bair B. Clozapine-induced toxic hepatitis. Am J Psychiatry 1995;152:296-7.
8. Jang SJ, Yi HT, Paek HJ, et al. Clozapine-induced acute hepatitis. J Korean Neuropsychiatr Assoc 1999;38:227-33.
9. Hovens JE, Vogtlander LM, Verhoeve HA, et al. Liver cell necrosis caused by clozapine. Ned Tijdschr Genneeskol 1994;138:365-8.
10. Hummer M, Jurz M, Jurzthaler I, et al. Hepatotoxicity of clozapine. J Clin Psychpharmacol 1997;17:314-7.
11. Gaertner I, Altendorf K, Batra A, et al. Relevance of liver enzyme elevations with four different neuroleptics: A retrospective review of 7263 treatment courses. J Clin Psychpharmacol 2001;21:215-22.